National Comprehensive Cancer Network



About NCCN

Prostate Cancer Panel - Disclosures as of 4/18/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Andrew J. Armstrong, MD, ScM

Active Biotech AB;
Bristol-Myers Squibb Company;
Dendreon Corporation;
ImClone Systems Incorporated;
Johnson & Johnson;
Novartis Pharmaceuticals Corporation;
Kanglaite;
Medivation;
Pfizer Inc.;
Pfizer Inc.;
sanofi-aventis U.S.

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Dendreon Corporation;
Johnson & Johnson;
Ipsen;
sanofi-aventis U.S.

None

None

5/15/2013

Robert R. Bahnson, MD

Aveo,Inc.

Aveo Pharmaceuticals

None

None

11/22/2013

Michael Cohen, MD

None

Myriad Genetic Laboratories, Inc.;
LivingstonBarger;
Otorowski, et al.;
Simmons Perrine et al.

None

None

6/26/2013

Anthony Victor D'Amico, MD, PhD

None

None

None

None

4/9/2014

James A. Eastham, MD

None

None

None

None

10/8/2012

Charles A. Enke, MD

None

Myriad Genetic Laboratories, Inc.

None

None

5/23/2013

Thomas A. Farrington, BSEE

None

None

None

None

8/6/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Celestia S. Higano, MD, FACP

Bayer HealthCare;
Exelixis Inc.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Aragon;
Medivation;
Teva

Abbott Laboratories;
Bayer HealthCare;
Genentech, Inc.;
Johnson & Johnson;
Millennium Pharmaceuticals, Inc.;
Ferring;
Medivation;
Pfizer Inc.

None

Dendreon Corporation;
Veridex, LLC

11/11/2013

Maria Ho, PhD

None

None

None

None

8/14/2013

Eric Mark Horwitz, MD

None

None

None

None

6/5/2013

Christopher J. Kane, MD, FACS

       

Pending

Philip W. Kantoff, MD

Bavarian Nordic Immunotherapy (BN-IT);
Oncogenix;
Takeda Pharmaceuticals North America, Inc.

Amgen Inc.;
Bayer HealthCare;
Celgene Corporation;
Dendreon Corporation;
Exelixis Inc.;
Genomic Health, Inc.;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Aragon Pharmaceuticals;
Archimedes Pharma US, Inc.;
Astellas;
Auven Therapeutics;
Bellicum;
BIND Biosciences, Inc.;
Blend Therapeutics;
BN Immunotherapeutics;
Endocyte/TRM Oncology;
GTx;
Medivation;
Metamark;
MorphoSys;
OncoCellMDX;
OncoGenex;
Progenics Pharmaceuticals;
Sotio;
Teva Oncogenix;
Tokai;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

4/15/2014

Mark H. Kawachi, MD

None

None

None

None

6/20/2013

Michael Kuettel, MD, MBA, PhD

None

None

None

None

10/9/2012

Timothy M. Kuzel, MD

Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
GlaxoSmithKline;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Alton Pharmaceuticals;
ARgos Therapeutics;
Aveo;
Biovex, Inc/Amgen

Boehringer Ingelheim GmbH;
Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Elorac;
Prometheus Laboratories;
Pfizer Inc.

None

None

7/3/2013

Richard J. Lee, MD, PhD

None

None

None

None

8/7/2012

Arnold W. Malcolm, MD, FACR

None

None

None

None

4/24/2013

Joan S. McClure, MS

None

None

None

None

8/13/2013

James L. Mohler, MD

Roswell Park Cancer Institute

Genomic Health, Inc.

None

Androbiosys, Inc.

2/25/2014

Elizabeth R. Plimack, MD, MS

Bristol-Myers Squibb Company;
Dendreon Corporation;
GlaxoSmithKline;
Merck & Co., Inc.;
Acceleron

Dendreon Corporation;
GlaxoSmithKline;
Astellas

None

None

8/3/2013

Julio M. Pow-Sang, MD

None

Myriad Genetic Laboratories, Inc.

None

None

3/29/2013

David Raben, MD

       

Pending

Sylvia Richey, MD

None

Astellas / Medivation Speaker

None

None

5/20/2013

Mack Roach III, MD

None

AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
;
ARISTA;
Astellas;
Ferring Pharma

None

None

5/23/2013

Eric Rohren, MD, PhD

None

None

None

None

5/17/2013

Stan Rosenfeld

None

None

None

None

10/22/2012

Edward Schaeffer, MD, PhD

Genome Dx

MetaMark Diagnostics

None

None

1/15/2014

Dorothy Shead, MS

None

None

None

None

8/19/2013

Ted Skolarus, MD, MPH

       

Pending

Eric J. Small, MD

None

None

None

None

1/9/2014

Guru Sonpavde, MD

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
sanofi-aventis U.S.

GlaxoSmithKline;
Millennium Pharmaceuticals, Inc.;
sanofi-aventis U.S.

None

None

12/19/2013

Sandy Srinivas, MD

Medivation

Johnson & Johnson;
Medivation;
medivation;
sanofi-aventis U.S.

None

None

12/9/2013

Cy Stein, MD, PhD

None

None

None

Amgen Inc.;
Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

3/28/2014

Seth A. Strope, MD, MPH

None

None

None

None

10/9/2012

Sarika Trikha

None

None

None

None

8/13/2013

Jonathan Tward, MD, PhD

None

Myriad Genetic Laboratories, Inc.

None

None

8/3/2012